Getting drugs and devices to the doorstep is only half the battle. When digital connections fail, trials fail. Why the digital last mile needs clinical supply ownership, human-centered design, and tech support with a bedside manner.
- The Site Perspective: Why Ambient AI Is The Missing Link In Clinical Trial Data Integrity
- Why HEOR Keeps Arriving Too Late — And How ClinOps Can Fix It
- Accelerating Clinical Innovation With Open-Source Medical Platforms
- From Supercomputers To The Cloud: How Pharma's R&D Infrastructure Transformation Impacts Clinical Trials
- How To Identify Patient-Centric Risks In The TMF With AI And Automation
- How The TMF Demonstrates Patient Safety And Rights In DCTs
- Begin Your AI-Led Digital Clinical Transformation With A Phased Approach
- How AI Is Rewriting The Future Of TMF And Clinical Quality
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Elevating Rater Training For More Reliable Study Outcomes
Well-trained raters are key to generating high-quality, consistent clinical trial data. Explore a program offering customized training tailored to the experience levels of raters.
-
The Importance Of Clinical Research-Focused AI In Data Management
Everyone in clinical research is eager to accelerate progress. Learn how to unlock insights from your data swiftly to accelerate the delivery of safe new therapies.
-
Embracing Accessibility: The Future Of Clinical Trials
Explore the reasons why accessibility stands as a crucial pillar for the prosperity of biopharmaceutical and clinical research, having evolved into an all-encompassing industry imperative.
-
EDC System Provides Flexibility, Scalability For Mid-Study Changes
Discover the importance of using a robust, scalable, and flexible EDC solution that handles mid-study changes for even the most complex clinical trials.
-
10 Roadblocks To Traditional Vendor Selection And How ClinAI Solves Them
Vendor selection in clinical trials is a pivotal process. Explore ten widespread inefficiencies in the current approach and how you can resolve them.
-
Real-World Evidence - Where Are We Now?
Notwithstanding ongoing confusion over the concepts of “real-world data” and “real-world evidence” in 2022, more than 5 years after the passage of the 21st Century Cures Act, the FDA continues to evaluate such data and evidence as it considers regulatory decisions.
-
It's Official: CRIO Sites Are Now 25% Of US Sites On Chronic Condition Studies
CRIO continues to lead the U.S. eSource market, with its platform widely adopted across clinical research sites. A recent analysis of 50 Phase 2 and 3 studies showed that, on average, 28% of U.S. sites were CRIO clients, with even higher adoption in key therapeutic areas.
-
Guide: How Connected Devices Improve Clinical Trial Data
Gain an overview of how and why connected devices provide sponsors and CROs with better clinical trial data, and offer patients much better trial experiences!
-
Calling All Assessment Authors: Do You Want To Share Your COA With Sponsors Across The Globe?
Explore how eCOAs will become an effective way to capture data remotely throughout the trial as sponsors shift to decentralized clinical trials.
-
Europe Has A Platform For Driving More Flexible Clinical Trials
Despite recent setbacks, Europe possesses inherent strengths in clinical research, and a concerted effort is needed to transform its potential into a thriving and competitive environment.